CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,083 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01309269
NCT01309269N/ACompleted

Non-interventional Study to Investigate the Long Term Effects of MIRCERA in Clinical Routine

Hoffmann-La Roche·observational·Posted Mar 7, 2011·Updated Nov 2, 2016

In Brief

An observational study for Anemia. Completed, enrolled 1,083 participants across 1 site.

Detailed Summary

This observational study will assess the effect of long-term treatment with Mircera (methoxy polyethylene glycol-epoetin beta) in chronic kidney disease patients with renal anemia. Data will be collected from each patient for at least 24 months.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMar 7, 2011
Enrollment StartSep 1, 2010
Primary CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 15.3 years ago